Drug Profile
Research programme: calcitonin gene-related peptide antagonists - Amgen
Alternative Names: AA95Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Amgen
- Class Monoclonal antibodies
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Migraine
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Migraine in USA (IV, Infusion)
- 31 Aug 2012 Preclinical trials in Migraine in USA (IV)